Related Experiment Videos
Changing patterns in drug therapy for ischemic heart disease
Insights
Physician prescribing habits for ischemic heart disease (IHD) changed significantly following beta-blocker studies and new calcium-channel blockers. More aggressive drug therapy, particularly beta-blockers, was observed in patients with myocardial infarction and unstable angina.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Physician prescribing patterns for ischemic heart disease (IHD) are influenced by clinical studies and drug availability.
- Beta-blocker therapy and calcium-channel blockers represent significant advancements in IHD management.
Purpose of the Study:
- To assess the impact of beta-blocker studies and calcium-channel blocker introduction on physician prescribing habits for IHD.
- To compare drug therapy in patients with myocardial infarction and unstable angina between 1980 and 1983-84.
Main Methods:
- Retrospective comparative study of 200 IHD patients (100 in 1980, 100 in 1983-84).
- Analysis of drug therapy prescribed at admission and discharge for patients with myocardial infarction and unstable angina.
- Statistical comparison of prescribing patterns between the two time periods.
Main Results:
- Significantly higher drug therapy rates for myocardial infarction patients in 1983-84 compared to 1980 (p<0.01 admission, p<0.001 discharge).
- Increased utilization of beta-blockers contributed to the rise in therapy for myocardial infarction.
- Calcium-channel blockers were increasingly used for unstable angina, with 20 patients on admission and 29 on discharge in 1983-84.
- Unstable angina consistently received more vigorous treatment than myocardial infarction in both study periods.
Conclusions:
- Physicians adopted a more aggressive drug therapy approach for IHD.
- The introduction of beta-blocker studies and calcium-channel blockers demonstrably influenced prescribing practices.
- Evidence suggests a positive shift towards more comprehensive management of ischemic heart disease.
Abstract:
To determine the possible influence of studies on beta-blocker therapy following myocardial infarction and the introduction of calcium-channel blockers on the prescribing habits of physicians in a large urban centre, the drug therapy received by 100 patients with ischemic heart disease (IHD) (50 with myocardial infarction and 50 with unstable angina) admitted to a university teaching hospital in 1980 was compared with that received by another such group of 100 patients admitted in 1983-84. The proportion of patients with myocardial infarction receiving drug therapy was significantly higher in 1983-84, at the time of both admission (p less than 0.01) and discharge (p less than 0.001). Much of the increase was due to greater use of beta-blockers. Of the 50 patients with unstable angina in 1983-84, 20 were taking calcium-channel blockers when admitted, and 29 were taking them when discharged. In both 1980 and 1983-84 unstable angina was treated more vigorously than myocardial infarction. The results suggest that physicians have developed a more aggressive approach to drug therapy for IHD since the publication of the beta-blocker studies and the introduction of calcium-channel blockers.